Letters Section Editor: Robert M. Golub, MD, Senior Editor.
To the Editor: The majority of the recommendations made by Dr Brennan and colleagues1 are necessary if somewhat overdue. Their discussion mirrors the conclusion of Healthy Skepticism in Australia—that at the present state of medical knowledge, we cannot “manage” gifts and financial exchanges with the pharmaceutical industry in such a way that we insure a greater likelihood of benefit than harm to patients.2
Brody H. Academic Medical Centers and Conflicts of Interest. JAMA. 2006;295(24):2845-2849. doi:10.1001/jama.295.24.2848-a